PubMed

Antithymocyte globulin for treatment of the bone marrow failure associated with myelodysplastic syndromes.

Molldrem JJ, Leifer E, Bahceci E, Saunthararajah Y, Rivera M, Dunbar C, Liu J, Nakamura R, Young NS, Barrett AJ.

Ann Intern Med. 2002 Aug 6;137(3):156-63.PMID: 12160363 [PubMed - indexed for MEDLINE]Related articlesFree article

Summaries for patients. Promising therapy for bone marrow failure from myelodysplastic syndromes.

[No authors listed]

Ann Intern Med. 2002 Aug 6;137(3):I-27. No abstract available. PMID: 12160383 [PubMed - indexed for MEDLINE]Related articlesFree article

Antithymocyte globulin and cyclosporine for severe aplastic anemia: association between hematologic response and long-term outcome.

Rosenfeld S, Follmann D, Nunez O, Young NS.

JAMA. 2003 Mar 5;289(9):1130-5.PMID: 12622583 [PubMed - indexed for MEDLINE]Related articlesFree article

Role of splenectomy in the treatment of myelodysplastic syndromes with peripheral thrombocytopenia: a report on six cases.

Bourgeois E, Caulier MT, Rose C, Dupriez B, Bauters F, Fenaux P.

Leukemia. 2001 Jun;15(6):950-3.PMID: 11417482 [PubMed - indexed for MEDLINE]Related articles

Prospective randomized multicenter study comparing cyclosporin alone versus the combination of antithymocyte globulin and cyclosporin for treatment of patients with nonsevere aplastic anemia: a report from the European Blood and Marrow Transplant (EBMT) Severe Aplastic Anaemia Working Party.

Marsh J, Schrezenmeier H, Marin P, Ilhan O, Ljungman P, McCann S, Socie G, Tichelli A, Passweg J, Hows J, Raghavachar A, Locasciulli A, Bacigalupo A.

Blood. 1999 Apr 1;93(7):2191-5.PMID: 10090926 [PubMed - indexed for MEDLINE]Related articlesFree article

A pilot study of antithymocyte globulin (ATG) in the treatment of patients with 'low-risk' myelodysplasia.

Killick SB, Mufti G, Cavenagh JD, Mijovic A, Peacock JL, Gordon-Smith EC, Bowen DT, Marsh JC.

Br J Haematol. 2003 Feb;120(4):679-84.PMID: 12588356 [PubMed - indexed for MEDLINE]Related articles

Serum erythropoietin (EPO) levels correlate with survival and independently predict response to EPO treatment in patients with myelodysplastic syndromes.

Wallvik J, Stenke L, Bernell P, Nordahl G, Hippe E, Hast R.

Eur J Haematol. 2002 Mar;68(3):180-5.PMID: 12068800 [PubMed - indexed for MEDLINE]Related articles

A prospective, randomised, phase II study of horse antithymocyte globulin vs rabbit antithymocyte globulin as immune-modulating therapy in patients with low-risk myelodysplastic syndromes.

Stadler M, Germing U, Kliche KO, Josten KM, Kuse R, Hofmann WK, Schrezenmeier H, Novotny J, Anders O, Eimermacher H, Verbeek W, Kreipe HH, Heimpel H, Aul C, Ganser A.

Leukemia. 2004 Mar;18(3):460-5.PMID: 14712285 [PubMed - indexed for MEDLINE]Related articles

Antithymocyte globulin for patients with myelodysplastic syndrome.

Molldrem JJ, Caples M, Mavroudis D, Plante M, Young NS, Barrett AJ.

Br J Haematol. 1997 Dec;99(3):699-705.PMID: 9401087 [PubMed - indexed for MEDLINE]Related articles

Factors affecting response and survival in patients with myelodysplasia treated with immunosuppressive therapy.

Sloand EM, Wu CO, Greenberg P, Young N, Barrett J.

J Clin Oncol. 2008 May 20;26(15):2505-11. Epub 2008 Apr 14.PMID: 18413642 [PubMed - indexed for MEDLINE]Related articles

Antithymocyte globulin treatment in patients with aplastic anemia: a prospective randomized trial.

Champlin R, Ho W, Gale RP.

N Engl J Med. 1983 Jan 20;308(3):113-8.PMID: 6336819 [PubMed - indexed for MEDLINE]Related articles

Long-term outcome of 25 children and adolescents with severe aplastic anemia treated with antithymocyte globulin.

de-Medeiros CR, Ribeiro RC, Bittencourt MA, Zanis-Neto J, Pasquini R.

Braz J Med Biol Res. 2000 May;33(5):553-8.PMID: 10775887 [PubMed - indexed for MEDLINE]Related articlesFree article

A phase-II trial of all trans retinoic acid and low-dose cytosine arabinoside for the treatment of high-risk myelodysplastic syndromes.

Venditti A, Tamburini A, Buccisano F, Scimò MT, Del Poeta G, Maurillo L, Cox MC, Abruzzese E, Tribalto M, Masi M, Amadori S.

Ann Hematol. 2000 Mar;79(3):138-42.PMID: 10803936 [PubMed - indexed for MEDLINE]Related articles

Antithymocyte globulin and cyclosporine A as combination therapy for low-risk non-sideroblastic myelodysplastic syndromes.

Broliden PA, Dahl IM, Hast R, Johansson B, Juvonen E, Kjeldsen L, Porwit-MacDonald A, Sjoo M, Tangen JM, Uggla B, Oberg G, Hellstrom-Lindberg E.

Haematologica. 2006 May;91(5):667-70.PMID: 16670072 [PubMed - indexed for MEDLINE]Related articlesFree article

Low-dose interleukin-11 in patients with bone marrow failure: update of the M. D. Anderson Cancer Center experience.

Tsimberidou AM, Giles FJ, Khouri I, Bueso-Ramos C, Pilat S, Thomas DA, Cortes J, Kurzrock R.

Ann Oncol. 2005 Jan;16(1):139-45.PMID: 15598951 [PubMed - indexed for MEDLINE]Related articlesFree article

Immunosuppressive therapy with anti-thymocyte globulin and cyclosporine A in selected children with hypoplastic refractory cytopenia.

Yoshimi A, Baumann I, Führer M, Bergsträsser E, Göbel U, Sykora KW, Klingebiel T, Gross-Wieltsch U, van den Heuvel-Eibrink MM, Fischer A, Nöllke P, Niemeyer C.

Haematologica. 2007 Mar;92(3):397-400.PMID: 17339190 [PubMed - indexed for MEDLINE]Related articlesFree article

Efficacy of lenalidomide in myelodysplastic syndromes.

List A, Kurtin S, Roe DJ, Buresh A, Mahadevan D, Fuchs D, Rimsza L, Heaton R, Knight R, Zeldis JB.

N Engl J Med. 2005 Feb 10;352(6):549-57.PMID: 15703420 [PubMed - indexed for MEDLINE]Related articlesFree article

[Immunosuppressive treatment of the myelodysplastic syndrome]

Larsen MS, Hasselbalch HC.

Ugeskr Laeger. 2003 Jun 23;165(26):2654-7. Danish. PMID: 12886548 [PubMed - indexed for MEDLINE]Related articles

Durable treatment-free remission after high-dose cyclophosphamide therapy for previously untreated severe aplastic anemia.

Brodsky RA, Sensenbrenner LL, Smith BD, Dorr D, Seaman PJ, Lee SM, Karp JE, Brodsky I, Jones RJ.

Ann Intern Med. 2001 Oct 2;135(7):477-83.PMID: 11578150 [PubMed - indexed for MEDLINE]Related articlesFree article

Treatment of severe aplastic anemia with antilymphocyte globulin, cyclosporine and two different granulocyte colony-stimulating factor regimens: a GITMO prospective randomized study.

Locasciulli A, Bruno B, Rambaldi A, Saracco P, Dufour C, Finelli C, Sica S, Varotto S, Arcese W, Locatelli F, Soligo D, Bacigalupo A; GITMO prospective randomized study.

Haematologica. 2004 Sep;89(9):1054-61.PMID: 15377466 [PubMed - indexed for MEDLINE]Related articlesFree article